Relief Pharmacist Revenue and Competitors
Estimated Revenue & Valuation
- Relief Pharmacist's estimated annual revenue is currently $32.4M per year.
- Relief Pharmacist's estimated revenue per employee is $201,000
Employee Data
- Relief Pharmacist has 161 Employees.
- Relief Pharmacist grew their employee count by -1% last year.
Relief Pharmacist Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.5M | 122 | 8% | N/A | N/A |
#2 | $10.7M | 53 | -17% | N/A | N/A |
#3 | $9.2M | 46 | 2% | N/A | N/A |
#4 | $24.1M | 120 | 5% | N/A | N/A |
#5 | $7.2M | 36 | -20% | N/A | N/A |
#6 | $27.7M | 138 | -30% | N/A | N/A |
#7 | $39.8M | 198 | 37% | N/A | N/A |
#8 | $0.5M | 5 | 25% | $50M | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $10.3M | 51 | 11% | N/A | N/A |
What Is Relief Pharmacist?
Relief Pharmacist is a pharmaceuticals company based out of 611 Valley Run Dr, Bremen, Georgia, United States.
keywords:N/A
N/A
Total Funding
161
Number of Employees
$32.4M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Relief Pharmacist News
2022-04-20 - Im a pharmacist and here are my 8 hay fever hacks
from stripping off to
Vaseline...
Use meds. Most people who have hay fever are usually stocked up with remedies, and Marc said there are a rage of relief products that you might...
2022-04-17 - Pharmacist Jerry Hoekwater retiring after six decades serving ...
Hoekwater said he basically acted as a relief pharmacist, giving the full-time pharmacists at these locations a chance to take some time...
2022-03-22 - Feds: Dearborn Heights man buys seaside condo with COVID relief money; wife
runs $10.6M pharmacy scheme
... two pharmacies in Inkster and the other for using $1 million in COVID relief money to buy a seaside condo in Beirut, officials said.
Other Companies in Bremen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $32.3M | 163 | 1% | N/A |
#2 | $67.4M | 250 | 12% | N/A |
#3 | $94.4M | 260 | -14% | N/A |
#4 | $55M | 314 | 24% | N/A |
#5 | N/A | 334 | 24% | N/A |